MCK AI Analysis Overview
Keys for Bullish View
- Value≥4
- Dividend≥2
Analysis Conclusion
The stock has a lower value rating and a moderate dividend score. If better value investment opportunities arise, consider partially switching stocks.
MCK Current Performance
0.74%
Mckesson corporation
1.19%
Avg of Sector
1.11%
S&P500
Top 10 High Relevance to MCK
| Symbol | Company Name | Value | Trend | Swing Trading | Whale Interest | Dividend | Add to Watchlist |
|---|---|---|---|---|---|---|---|
COR | Cencora inc | 4 | 2 | 4 | 2 | 4 | |
CVS | Cvs health corp | 4 | 3 | 4 | 3 | 5 | |
REYN | Reynolds consumer products inc | 5 | 1 | 3 | 2 | 3 | |
CL | Colgate-palmolive co. | 4 | 5 | 2 | 4 | 5 | |
KR | Kroger co | 5 | 4 | 4 | 3 | 5 |
- COR Cencora incValue 4Trend 2Swing Trading 4Whale Interest 2Dividend 4See more
MCK Profile
McKesson Corporation is a provider of diversified healthcare services. The Company is engaged in advancing health outcomes for patients everywhere. Its U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over the counter (OTC) pharmaceutical drugs and other healthcare-related products in the United States. Its Prescription Technology Solutions segment helps solve medication access, affordability, and adherence challenges for patients by working across healthcare to connect patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies. Its Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home healthcare agencies. Its International segment provides distribution and services to wholesale, institutional, and retail customers in Europe and Canada.